• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Hygiene and Health: Are We Too Clean?

Slideshow

How do we combat waning human immunity? Our slide show summarizes 5 new reports that suggest it’s essential to figure that out.

Modern hygiene and health has been the topic of a variety of recent reports in prestigious scientific journals and in the popular press. We summarize 5 in our short slide show, below. Some conclusions may already be common knowledge, but others may be worth discussion in clinical practice.

Recent Videos
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Related Content
FDA May End Use of Oral Phenylephrine as Nasal Decongestant Ingredient in OTC Products

FDA May End Use of Oral Phenylephrine as Nasal Decongestant Ingredient in OTC Products

Grace Halsey
November 8th 2024
Article

A decision on ending use of oral phenylephrine as a nasal decongestant in OTC products will be made following public comment on FDA's proposed order.

Hepatitis C: What If You Do Not Treat?

Hepatitis C: What If You Do Not Treat?

Rodger D. MacArthur, MD;Merin Varghese, MD
April 18th 2017
Podcast

Severe outcomes may ensue in a high percentage of patients. The authors discuss the consequences in this brief podcast.

©Rawpixel/shutterstock.com

sNDA Goes to FDA for neffy 1 mg for Young Children with Type 1 Allergic Reactions

Grace Halsey
September 11th 2024
Article

The needle-free nasal spray, if approved, would be the first new administration method for epinephrine in young children in 35 years.

FDA Approves Neffy as First Nasal Spray for Allergic Reactions: Daily Dose / image credit: ©New Africa/AdobeStock

FDA Approves Neffy as First Nasal Spray for Allergic Reactions: Daily Dose

Sydney Jennings
August 20th 2024
Article

Your daily dose of the clinical news you may have missed.

FDA Approves First Intranasal Epinephrine for Emergency Treatment of Allergic Reactions image credit ©Waldenmarus/stock.adobe.com

FDA Approves First Intranasal Epinephrine for Emergency Treatment of Allergic Reactions

Grace Halsey
August 9th 2024
Article

neffy (epinephrine nasal spray) is the first alternative to epinephrine administered by autoinjector or syringe and is comparable in efficacy to the gold standard.

Topline Data Released on Self-Administered Epinephrine Sublingual Film for Severe Allergy / image credit breathing difficulty: ©New Africal/stock.adobe.com

Topline PK Data Released on Self-Administered Epinephrine Sublingual Film for Severe Allergy

Grace Halsey
July 26th 2024
Article

PK data from a self-administration study are comparable to those seen following administration by a clinician and Tmax equal at 15 minutes.

© 2024 MJH Life Sciences

All rights reserved.